Grace Therapeutics, Inc. (GRCE)
Stock-Based Compensation
$105.00K
Quarterly · Period ending: · USD
GRCE Stock-Based Compensation
Latest reported$105.00Kperiod ending
Latest reported$105.00Kperiod ending
GRCE Quarterly Stock-Based Comp ($0.00 → $105.00K)
Quarterly stock-based compensation
High-resolution chart · PNG
GRCE stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 105,000 | |
| -24,000 | |
| 314,000 | |
| 0 | |
| 302,000 | |
| 130,000 | |
| 160,000 | |
| 202,000 | |
| 238,000 | |
| 229,000 | |
| 326,000 | |
| 280,000 | |
| 78,000 | |
| 322,000 | |
| 443,000 | |
| 582,000 | |
| 464,000 | |
| 616,000 | |
| 454,000 | |
| 114,000 | |
| 189,221 | |
| 214,818 | |
| -38,306 | |
| 533,572 | |
| 857,153 | |
| 345,361 | |
| 611,000 | |
| 650,000 | |
| 250,000 | |
| 109,335 | |
| 246,690 | |
| 252,320 | |
| 190,845 | |
| 193,722 | |
| 262,425 | |
| 237,801 | |
| 27,680 | |
| 115,366 | |
| 160,419 | |
| 49,836 | |
| 77,393 | |
| 32,877 | |
| 61,494 | |
| 60,857 | |
| 22,777 | |
| 245,311 | |
| 387,522 | |
| 639,410 | |
| 641,021 | |
| 1,007,149 | |
| 942,197 | |
| 524,828 | |
| 398,600 | |
| 414,458 | |
| 526,667 | |
| 513,961 | |
| 551,917 | |
| 342,710 | |
| 305,562 | |
| 151,807 | |
| 45,312 | |
| 56,615 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |